Taking Sedation to a New Place

The SEDASYS® Computer-Assisted Personalized Sedation System

A new way for trained physician-led teams to safely and effectively deliver propofol on-label for minimal-to-moderate sedation in routine colonoscopy and esophogogastroduodenoscopy (EGD) procedures.

The SEDASYS® System is indicated for the intravenous administration of 1% (10 mg/mL) propofol injectable emulsion for the initiation and maintenance of minimal-to-moderate sedation, as defined by the American Society of Anesthesiologists (ASA) Continuum of Depth and Sedation, in ASA physical status I and II patients ≥ 18 years old undergoing colonoscopy or esophagogastroduodenoscopy (EGD) procedures.

For complete indications, contraindications, warnings, precautions, adverse events, and additional product information, see Instructions for Use and Essential Product Information.

Redefining how you look at sedation

Computer-assisted personalized sedation (CAPS) represents a paradigm shift in sedation delivery that can help address challenges in the current healthcare environment.

Learn more about this new option for delivering sedation

Innovative technology for personalized drug delivery and dosing

The SEDASYS® System delivers personalized drug titration along with safeguards against the risks of oversedation.

Explore how the System works and its safety features

Effective and efficient

The clinical benefits of the System were established in a pivotal clinical study that compared the SEDASYS® System with the current standard of care (benzodiazepine/opioid) sedation. With the SEDASYS® System, patients were minimally to moderately sedated, recovered faster and in more predictable timeframes and were highly satisfied with their sedation experience. Physicians were also significantly more satisfied with the sedation delivered.

Review the clinical study data